CADTH Pharmaceutical Reviews Update — Issue 12

See Pharmaceutical Reviews Update – Issue 12 for important news and information regarding CADTH’s drug review programs. Highlights from this issue include:

  • A new process for the submission and review of cell and gene therapies
  • Updated guidelines on fees for CADTH pharmaceutical reviews
  • Pending updates to the category 1 requirements
  • Pending changes to CADTH conflict of interest policies
  • A reminder about CADTH’s redaction policy
  • Information about a new advisory committee for CADTH’s drug portfolio